Copyright: ©Author(s) 2026.
World J Gastroenterol. Dec 28, 2026; 32(48): 121570
Published online Dec 28, 2026. doi: 10.3748/wjg.121570
Published online Dec 28, 2026. doi: 10.3748/wjg.121570
Figure 4 Prognostic value of pre- and post-treatment cadherin 17 and carbohydrate antigen 19-9 in the plasma samples of advanced pancreatic adenocarcinoma.
Kaplan-Meier curves showing 2-year survival rates for late-stage (III/IV) pancreatic cancer patients, stratified by median-high or median-low pre- and post-treatment levels. A: Cadherin 17; B: Carbohydrate antigen 19-9 analyzed individually; C: In combination. Statistical significance was assessed using the Log-rank (Mantel-Cox) test. CDH17: Cadherin 17; CA19-9: Carbohydrate antigen 19-9.
- Citation: Cho WC, Yu WS, Hon TC, Cheung ETY, Wang XQ, Wong DA, Wong CSC, Cheuk W, Luk JM. Cadherin-17: A potential biomarker for early detection in pancreatic adenocarcinoma. World J Gastroenterol 2026; 32(48): 121570
- URL: https://www.wjgnet.com/1007-9327/full/v32/i48/121570.htm
- DOI: https://dx.doi.org/10.3748/wjg.121570